Craneware plc Director/PDMR Shareholding (6518E)
11 Aprile 2014 - 1:05PM
UK Regulatory
TIDMCRW
RNS Number : 6518E
Craneware plc
11 April 2014
Craneware plc
("Craneware", "the Group" or the "Company")
Director Shareholding
11 April 2014 - Craneware plc (AIM: CRW.L), the market leader in
automated revenue integrity solutions for the US healthcare market,
has been informed that Matrix Alpha Analytics, a company in which
Neil Heywood, a non-executive director of the Company has an
interest, yesterday sold 9,000 ordinary shares of 1 pence each in
the Company ("Ordinary Shares") at an average price of 541.5 pence
per share.
Following these transactions, Neil Heywood has an interest in
the Company of 96,356 Ordinary Shares, representing approximately
0.36 per cent. of the Company's issued Ordinary Share capital.
For further information, please contact:
Craneware plc Peel Hunt Newgate Threadneedle
+44 (0)131 550 3100 +44 (0)20 7418 8900 +44 (0)20 7653 9850
Keith Neilson, CEO Dan Webster Caroline Forde
Craig Preston, CFO Richard Kauffer Fiona Conroy
Heather Armstrong
About Craneware
Founded in 1999, Craneware has headquarters in Edinburgh,
Scotland with offices in Atlanta, Arizona, Massachusetts and
Tennessee employing over 200 staff. Craneware is the leader in
automated revenue integrity solutions that improve financial
performance for healthcare organisations. Craneware's
market-driven, SaaS solutions help hospitals and other healthcare
providers more effectively price, charge, code and retain earned
revenue for patient care services and supplies. This optimises
reimbursement, increases operational efficiency and minimises
compliance risk. By partnering with Craneware, clients achieve the
visibility required to identify, address and prevent revenue
leakage. To learn more, visit craneware.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAFLFFEALEFF
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024